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Methods	
Introduc(on	
In	recent	years,	advancements	in	gene(c	
tes(ng	methods	have	revolu(onized	the	
medical	ﬁeld	by	enhancing	the	ability	to	
iden(fy	persons	with	an	inherited	
predisposi(on	to	cancer.	This	project	was	
designed	to	inves(gate	the	methods	used	in	
gene(c	tes(ng	as	well	as	demonstrate	the	
importance	of	implemen(ng	gene(c	tests	to	
individuals	who	appear	to	be	at	risk	for	
cancer.		
To	complete	this	project,	I	did	research	on	the	
methods	used	in	gene(c	tes(ng,	speciﬁcally	for	
those	with	an	inherited	predisposi(on	to	cancer.	
To	supplement	this	research,	a	real	world	case	
study	was	evaluated.	An	individual	who	
underwent	the	Myriad	myRisk®	gene(c	test	and	
presented	with	a	muta(on	known	as	Lynch	
Syndrome	was	studied.	I	produced	an	inclusive	
research	paper	that	highlights	the	posi(ve	impact	
of	gene(c	tes(ng	by	dissec(ng	the		pathogenesis	
of	Lynch	Syndrome	at	a	molecular	level.		
Results	
Gene$c	Tes$ng	
	
	
	
	
	
	
Gene(cists	search	for	speciﬁc	markers	within	the	
human	genome	that	are	indicators	of	an	inherited	
cancer	syndrome.		
	
	
	
	
	
	
Case	Study		
	The	pa(ent	underwent	the	Myriad	myRisk®	test,	which	
uncovered	a	gene(c	muta(on	in	her	genome	classiﬁed	
as	Lynch	Syndrome.	Tes(ng	revealed	the	muta(on	c.
113del	(p.Thr45Glnfs*5).	This	muta(on	results	in	
premature	trunca(on	of	the	MLH1	protein.		
	
Lynch	Syndrome	
Lynch	syndrome,	or	hereditary	non-
polyposis	colon	cancer	(HNPCC),	is	an	
autosomal	dominant	disease	that	leads	to	
colon	cancer	as	well	as	increased	risk	to	
many	other	cancers	due	to	the	inac(va(on	
or	altered	func(on	of	integral	DNA	
mismatch	repair	genes.	
	
	
	
	
	
	
	
	
	
	
	
	
•  Mismatch	repair	genes	mutated	in	LS:	
MLH1,	MSH2,	MSH6,	PMS2,	EPCAM	
•  3-5%	of	colorectal	cancers	arise	from	LS	
•  One	of	the	most	common	hereditary	
cancer	syndromes	
•  Increased	risk	of	many	abdominal	and	
reproduc(ve	cancers	
Classiﬁca1on	of	the	3	main	types	of	gene1c	tes1ng	(1).	
The	Myriad	myRisk®	Hereditary	Cancer	Test	is	a	28-gene	panel	that	
iden1ﬁes	an	elevated	risk	for	8	cancers	(2).	
Cytogene1c	loca1on	of	MLH1	gene	on	chromosome	3		3p22.2	(3).	
PaLern	of	inheritance	in	Lynch	Syndrome	families	
